Beijing Tong Ren Tang Chinese Medicine Dirección
Dirección controles de criterios 0/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Wang Chi
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | less than a year |
| Participación del CEO | n/a |
| Permanencia media de la dirección | less than a year |
| Promedio de permanencia en la Junta Directiva | 2.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up
Oct 04
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders
Sep 06Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?
Sep 02Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk
Feb 05Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Jan 03A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Sep 28Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today
Jul 12Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?
Mar 29Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28
Apr 28Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28
Mar 25Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?
Oct 27Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 28Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Mar 11What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Feb 04Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?
Jan 18
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?
Dec 29Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Dec 11Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 23CEO
Wang Chi (49 yo)
less than a year
Permanencia
Mr. Wang Chi is Executive Director and Chief Executive Officer of Beijing Tong Ren Tang Chinese Medicine Company Limited from May 10, 2024. Mr. Chi has experience in Medical and Pharmaceutical industry. Mr...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | sin datos | sin datos | |
| Executive Director & Executive Deputy GM | less than a year | HK$975.00k | 0.0073% HK$ 479.0k | |
| CEO & Executive Director | less than a year | sin datos | sin datos | |
| CFO & Company Secretary | 4.5yrs | sin datos | sin datos | |
| Deputy GM & General Counsel | no data | sin datos | sin datos |
0.7yrs
Permanencia media
50yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 3613 no se considera experimentado ( 0.7 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | sin datos | sin datos | |
| Executive Director & Executive Deputy GM | 4.7yrs | HK$975.00k | 0.0073% HK$ 479.0k | |
| CEO & Executive Director | less than a year | sin datos | sin datos | |
| Independent Non-Executive Director | 7.2yrs | HK$288.00k | sin datos | |
| Independent Non-Executive Director | 11.6yrs | HK$288.00k | sin datos | |
| Non-Executive Director | 2.3yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 1.7yrs | HK$240.00k | sin datos |
2.3yrs
Permanencia media
53yo
Promedio de edad
Junta con experiencia: La junta directiva de 3613 no se considera experimentada (2.3 años de permanencia promedio), lo que sugiere una nueva junta directiva.